美国德克萨斯大学安德森癌症中心癌症药物遗传学博士后职位
2014-09-05 11:12 来源: 未知 作者: liuxuehr
Postdoctoral positions in the field of cancer pharmacogenomics are available immediately in Dr. Xifeng Wu's lab at The University of Texas MD Anderson Cancer Center. Fellows are being recruited for projects aimed at identifying biomarkers for the prediction of cancer treatment outcomes by integrating genetic variation information with clinical and epidemiological data utilizing our well-characterized patient populations and extensive collection of biospecimens. Dr. Wu's research group successfully executes contemporary epidemiologic strategies across the cancer continuum by employing advanced, state-of-the-art equipment including high- and mid-throughput assay platforms for genotyping, copy number analysis, next-generation sequencing, whole-genome expression profiling, as well as microRNA and metabolome profiling. Our capabilities include single-cell and high-content analysis, FISH, telomere length and mitochondrial DNA analysis, and other cell-based phenotypic studies.
声明：凡本网注明"来源：XXX"的文/图等稿件，本网转载出于传递更多信息及方便产业探讨之目的，并不意味着本站赞同其观点或证实其内容的真实性，文章内容仅供参考。如其他媒体、网站或个人从本网站转载使用，须保留本网站注明的“来源”，并自负版权等法律责任。作者如果不希望被转载或者联系转载等事宜，请与我们联系。
